AstraZeneca, Trump ink deal to cut U.S. drug prices
LONDON: AstraZeneca today announced a historic agreement with President Donald J. Trump’s administration to lower the cost of prescription medicines for American patients while preserving America’s cutting-edge biopharmaceutical innovation. At a landmark event at the White House, AstraZeneca CEO Pascal…